The ongoing COVID-19 pandemic continues to present an extraordinary challenge to global health, complicated by rapidly evolving epidemiology, wrote the U.S. Food and Drug Administration (FDA) in a Briefing Document published today.
The Future Vaccination Regimens Addressing COVID-19 document was prepared for the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting scheduled for January 26, 2023.
Excerpts from the Executive Overview are inserted below:
Read More
